Aerospace systems provider Astronics Corporation launches its new automated circuit card testing system, designed to accelerate troubleshooting and maintenance for critical aviation and defense electronics, as analysts raise price targets on sustained sector demand.
Terns Pharmaceuticals has restructured a key licensing deal with China's Hansoh, gaining exclusive worldwide rights for its TERN-701 oncology drug outside Greater China. The strategic move, coupled with a recent analyst price target surge, signals the company's aggressive push into international markets.
Iran has summoned the ambassadors of all European Union member states in Tehran in a sharp diplomatic protest against the bloc's move to formally designate the Islamic Revolutionary Guard Corps (IRGC) as a terrorist organization.
Short interest in beverage giant Constellation Brands has declined, signaling a potential shift in trader sentiment. However, the level remains elevated compared to industry rivals, highlighting ongoing debate over the stock's valuation amid shifting consumer trends.
A major grant from Centene's foundation aims to tackle housing insecurity for justice-involved individuals in Chicago, spotlighting the healthcare giant's community investments as its stock faces persistent headwinds.
Takeda Pharmaceutical raises its FY2025 revenue and profit guidance following resilient nine-month results and announces U.S. availability of a new ready-to-use immunoglobulin therapy for primary immunodeficiency, fueling discussions on its growth strategy amid high debt and margin pressures.
As the EU's landmark 'Next Generation' fund nears its final payout deadlines, its ambitious goal of modernizing the bloc's economy is being hampered by bureaucracy, skills gaps, and questions over long-term sustainability, despite pockets of innovation.
The FDA has cleared Intuitive Surgical's latest robotic system for use in certain heart surgeries, marking a strategic expansion into one of healthcare's largest and most complex service lines and potentially reshaping hospital capital planning for robotics.
Palantir Technologies expands its strategic footprint in Asia through a deepened partnership with HD Hyundai, while securing a pivotal role in building sovereign AI data centers across Europe, the Middle East, and Africa with Sovereign AI and Accenture.
The decentralized finance protocol has publicly identified wallets linked to a weekend exploit, warning of criminal and civil action if funds are not returned within 72 hours, as security firms point to a critical validation flaw.
Amidst a patchy economic recovery, European small-cap stocks are back in focus. A surge in insider buying activity points to potential undervaluation in select names across property, cybersecurity, and defense tech sectors.
Amid a patchy market recovery, savvy investors are scouring Europe for hidden gems. We spotlight three companies—from shipping to sportswear—whose current share prices appear significantly discounted against their intrinsic value, presenting potential opportunities for long-term growth.
As confidence in the Eurozone's recovery builds, investors are scrutinizing companies where executives hold significant equity stakes—a potential signal of alignment and long-term conviction. We spotlight three firms from a broader screen of 220 high-insider-ownership growth stocks.
Amidst a cautiously recovering Eurozone economy, we spotlight three lesser-known European companies—spanning finance, telecom, and food production—that combine strong fundamentals with compelling growth narratives for discerning investors.
IDEAYA Biosciences shares have retreated from recent highs, presenting investors with a dilemma. While long-term performance remains strong, its premium valuation and significant net losses raise questions about whether the current price already reflects its promising pipeline.
Vital Farms shares have tumbled over 35% in the past year, lagging the broader market. A deep dive into valuation metrics, including DCF analysis and P/E comparisons, suggests the stock may be significantly undervalued. But is the market missing something?
Chinese EV maker Li Auto announces a significant organizational overhaul, dissolving its dedicated autonomous driving team to focus resources on 'embodied intelligence' and humanoid robotics, signaling a bold strategic realignment.
Chinese electric vehicle maker NIO reports a near-doubling of January deliveries year-over-year, surpassing one million cumulative vehicles. The company is pushing into new markets in Europe and Asia while rolling out a major driver-assistance system upgrade to its existing fleet, even as it navigates subsidy reductions and intensifying competition at home.
Orchid Island Capital, Inc. (NYSE:ORC) reported a dramatic surge in full-year 2025 net income, driven by a strategic expansion of its agency MBS portfolio and disciplined hedging. The results mark a potential inflection point for the mortgage REIT, reshaping its risk-reward profile after years of uneven performance.
Iran's Supreme Leader Ali Khamenei has issued a stark warning that any U.S. military action against Tehran would escalate into a regional war, accusing Washington of coveting Iran's energy resources. The warning comes amid heightened tensions and internal unrest following deadly protests.
